Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-3-31
pubmed:abstractText
Targeted disruption of the surfactant protein (SP) D (SP-D) gene caused a marked pulmonary lipoidosis characterized by increased alveolar lung phospholipids, demonstrating a previously unexpected role for SP-D in surfactant homeostasis. In the present study, we tested whether the local production of SP-D in the lung influenced surfactant content in SP-D-deficient [SP-D(-/-)] and SP-D wild-type [SP-D(+/+)] mice. Rat SP-D (rSP-D) was expressed under control of the human SP-C promoter, producing rSP-D, SP-D(+/+) transgenic mice. SP-D content in bronchoalveolar lavage fluid was increased 30- to 50-fold in the rSP-D, SP-D(+/+) mice compared with the SP-D(+/+) parental strain. Lung morphology, phospholipid content, and surfactant protein mRNAs were unaltered by the increased concentration of SP-D. Likewise, the production of endogenous mouse SP-D mRNA was not perturbed by the SP-D transgene. rSP-D, SP-D(+/+) mice were bred to SP-D(-/-) mice to assess whether lung-selective expression of SP-D might correct lipid homeostasis abnormalities in the SP-D(-/-) mice. Selective expression of SP-D in the respiratory epithelium had no adverse effects on lung function, correcting surfactant phospholipid content and decreasing phosphatidylcholine incorporation significantly. SP-D regulates surfactant lipid homeostasis, functioning locally to inhibit surfactant phospholipid incorporation in the lung parenchyma and maintaining alveolar phospholipid content in the alveolus. Marked increases in biologically active tissue and alveolar SP-D do not alter lung morphology, macrophage abundance or structure, or surfactant accumulation.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1040-0605
pubmed:author
pubmed:issnType
Print
pubmed:volume
278
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
L365-73
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:10666121-Animals, pubmed-meshheading:10666121-Bronchoalveolar Lavage Fluid, pubmed-meshheading:10666121-Gene Expression, pubmed-meshheading:10666121-Gene Targeting, pubmed-meshheading:10666121-Glycoproteins, pubmed-meshheading:10666121-Homeostasis, pubmed-meshheading:10666121-Humans, pubmed-meshheading:10666121-Lipid Metabolism, pubmed-meshheading:10666121-Lung, pubmed-meshheading:10666121-Mice, pubmed-meshheading:10666121-Mice, Inbred Strains, pubmed-meshheading:10666121-Mice, Transgenic, pubmed-meshheading:10666121-Phosphatidylcholines, pubmed-meshheading:10666121-Phospholipids, pubmed-meshheading:10666121-Pulmonary Surfactant-Associated Protein D, pubmed-meshheading:10666121-Pulmonary Surfactants, pubmed-meshheading:10666121-RNA, Messenger, pubmed-meshheading:10666121-Rats, pubmed-meshheading:10666121-Recombinant Proteins, pubmed-meshheading:10666121-Transgenes
pubmed:year
2000
pubmed:articleTitle
Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice.
pubmed:affiliation
Pulmonary/Critical Care Medicine, Denver Health Medical Center and University of Colorado Health Sciences Center, Denver, Colorado 80262, USA. Jfisher@DHHA.org
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.